This week, James is joined by Dr Sai Narimetla, an A&E doctor who simultaneously works in investment banking at SSG Capital, to ask why healthtech hasn't produced the exits that biotech and medical devices have. They get into fragmentation, why the deals that are happening don't make headlines, and what a clinical lens actually adds when you're diligencing a company.


Connect with Sai: https://www.linkedin.com/in/sainarimetla/

Learn more about SSG Capital: https://www.ssgcapital.uk/


Apply to be a guest: https://www.thehealthtechpodcast.com

Subscribe to Healthtech Pigeon: https://www.healthtechpigeon.com

Get in touch with James: https://www.jamessomauroo.com


This podcast was brought to you by SomX.


Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör Dr. James Somauroo. Innehållet i podden är skapat av Dr. James Somauroo och inte av, eller tillsammans med, Poddtoppen.